
July to September 2023
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $146,945,827 | 6,878 |
| PEMBROLIZUMAB | $124,544,644 | 14,488 |
| NIVOLUMAB | $113,331,604 | 15,729 |
| AFLIBERCEPT | $105,121,693 | 107,353 |
| USTEKINUMAB | $102,946,234 | 13,978 |
| APIXABAN | $84,786,401 | 1,033,628 |
| DUPILUMAB | $81,765,239 | 47,606 |
| SEMAGLUTIDE | $74,227,669 | 618,278 |
| DENOSUMAB | $70,529,161 | 277,446 |
| ADALIMUMAB | $61,957,140 | 85,901 |
| OCRELIZUMAB | $54,956,133 | 3,349 |
| MOLNUPIRAVIR | $51,039,060 | 41,668 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $33,591,475 | 4,450,533 |
| ATORVASTATIN | $26,819,910 | 3,143,297 |
| PANTOPRAZOLE | $23,748,272 | 2,711,138 |
| ESOMEPRAZOLE | $20,731,497 | 2,113,987 |
| PERINDOPRIL | $13,749,475 | 1,847,386 |
| ESCITALOPRAM | $7,652,428 | 1,600,724 |
| METFORMIN | $13,594,788 | 1,557,934 |
| AMOXICILLIN | $6,253,349 | 1,549,902 |
| SERTRALINE | $7,888,165 | 1,496,225 |
| AMLODIPINE | $10,598,612 | 1,321,775 |
| CEFALEXIN | $7,223,474 | 1,281,064 |
| TELMISARTAN | $8,313,683 | 1,187,536 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,381,470,565 |
| Patients | $845,711,074 |